Objective To quantify the association between atrial fibrillation and cardiovascular disease,
renal disease, and death. Design Systematic review and meta-analysis. Data sources …

Objective To determine whether atrial fibrillation is a stronger risk factor for cardiovascular
disease and death in women compared with men. Design Meta-analysis of cohort studies …

Despite major improvements in primary prevention and acute treatment over the last
decades, stroke is still a devastating disease. At the beginning of the 21st century, the age …

Summary Background About 13–26% of all acute ischaemic strokes are related to non-
valvular atrial fibrillation, the most common cardiac arrhythmia globally. Deciding when to …

Because of the growing size and aging of the world's population, the global burden of stroke
is increasing dramatically. Current epidemiological data indicate that 16.9 million people …

Background and Purpose—Atrial fibrillation (AF) is a common cause of devastating but
potentially preventable stroke. Estimates of the prevalence of AF among patients with stroke …

Background In the ARISTOTLE trial, the rate of stroke or systemic embolism was reduced by
apixaban compared with warfarin in patients with atrial fibrillation (AF). Patients with AF and …

Atrial fibrillation (AF) is the most common clinical arrhythmia and is associated with
increased morbidity and mortality. There is growing evidence that numerous cardiovascular …

Background: We aimed to evaluate the impact of the ageing population on temporal trends
in burden of stroke and to provide projections for the coming years. Methods: Stroke cases …

There remains uncertainty over optimal antithrombotic management strategy for patients
with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing …